Compare TULP & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TULP | NCEL |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | Switzerland |
| Employees | 160 | 4 |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 20.6M |
| IPO Year | N/A | N/A |
| Metric | TULP | NCEL |
|---|---|---|
| Price | $4.05 | $3.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.6K | ★ 51.0K |
| Earning Date | 02-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.61 | $1.83 |
| 52 Week High | $4.79 | $5.12 |
| Indicator | TULP | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 49.53 |
| Support Level | $3.65 | $3.03 |
| Resistance Level | $4.06 | $3.54 |
| Average True Range (ATR) | 0.15 | 0.27 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 67.80 | 26.67 |
Bloomia Holdings Inc is a specialty ag company focused on making and managing its ag investments in the U.S. and internationally. The Company is the majority owner of Bloomia, one of the largest producers of fresh-cut tulips in the United States.
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.